1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Bremerton, Washington. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Bremerton.
Bremerton, Washington has 1 SAMHSA-verified addiction treatment center offering 1 dual diagnosis, 1 outpatient. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Outpatient programs allow Bremerton residents to receive treatment while maintaining their daily responsibilities. Sessions are typically scheduled 3-5 days per week, making it possible to continue working or attending school.
Treatment centers in Bremerton accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Withdrawal from alcohol or benzodiazepines can be medically dangerous and should not be attempted at home by Bremerton residents with daily or heavy use. Signs of severe withdrawal requiring emergency care include seizures, hallucinations, severe tremor, disorientation, fever, and autonomic instability. Delirium tremens (DTs) carries 5% mortality without treatment and occurs in 3-5% of heavy alcohol users withdrawing. Medical detox at a licensed Bremerton facility is the standard of care for these presentations.
Employment re-entry after addiction treatment is a Bremerton priority that intersects with long-term recovery sustainability. The Americans with Disabilities Act protects employees in recovery from discrimination based on past substance use (current illegal use is not protected). FMLA may apply to treatment-related absences. State vocational rehabilitation services offer career counseling, education funding, and job placement support. Recovery-friendly employer initiatives are emerging in many U.S. markets including Washington.
Bremerton sits within Washington's broader addiction-treatment infrastructure — a network of licensed providers ranging from medically supervised detox facilities through residential treatment, partial hospitalization, intensive outpatient, and standard outpatient counseling. Patients seeking care in Bremerton have access to options at multiple intensity levels, with placement decisions driven by ASAM criteria: withdrawal risk, biomedical conditions, emotional/behavioral status, readiness to change, relapse potential, and the patient's current recovery environment. The specific providers verified for Bremerton below represent facilities that have been confirmed against SAMHSA's treatment-locator database and Washington licensing records.
Federal parity protections extend beyond just coverage existence to specific plan design elements: prior authorization burden, treatment day limits, financial requirements, and non-quantitative treatment limits must all be comparable between substance-use and medical/surgical benefits. Bremerton patients encountering insurer practices that appear to discriminate against addiction-treatment access can file complaints with the Washington Department of Insurance, the U.S. Department of Labor (for ERISA plans), or the federal Center for Consumer Information and Insurance Oversight.
Bipolar disorder requires specific clinical management in Bremerton addiction-treatment settings: medication stabilization typically precedes deeper psychotherapy work, manic-phase substance use must be distinguished from continued substance use during depressive phases, and treatment planning accommodates the mood-cycling nature of the condition. Patients with bipolar disorder benefit from longer treatment episodes and more intensive aftercare than typical residential patients — relapse risk runs higher and clinical stabilization takes longer.
Family involvement in Bremerton program admission typically begins with the admissions call itself — many patients seeking treatment have a family member or partner initiating the contact. Most facilities allow family conversations during the admission process (subject to 42 CFR Part 2 confidentiality), schedule family education or therapy sessions early in treatment, and explicitly involve family in discharge planning. Family-system engagement correlates with better treatment outcomes across the literature.
Medication-assisted treatment (MAT) for opioid use disorder is available in Bremerton through multiple pathways: federally certified Opioid Treatment Programs (OTPs) dispensing methadone, office-based buprenorphine prescribers (now expanded after the X-waiver elimination), and extended-release naltrexone (Vivitrol) at clinics willing to administer the monthly injection. Each medication has clinical use cases — methadone for severe long-standing opioid use disorder, buprenorphine for outpatient maintenance, naltrexone for patients fully detoxed and committed to abstinence-based recovery.